Chikungunya IgM Rapid Test

A virus called chikungunya is transmitted by mosquitoes. Although you cannot contract it from another person, mosquitoes can contract it by biting an infected person. Most individuals don't pass away from it, although you can have some long-lasting agony. In fact, the African Makonde language name of the chikungunya virus translates to "bent over in anguish." The majority of those who get the chikungunya virus will have some symptoms. The typical onset of symptoms is 3–7 days after being bitten by an infected mosquito.

Fever and joint discomfort are the most frequent signs and symptoms. Other signs include be a rash, headache, muscular soreness, or joint swelling. Newborns infected at the time of delivery, elderly persons (>65), and those with medical disorders including high blood pressure, diabetes, or heart disease are among those who are at risk for a more severe illness. The majority of patients recover within a week. Joint discomfort, however, can be extremely painful and incapacitating and last for weeks. Chikungunya is seldom fatal.

The Chikungunya IgM Rapid Test is an easy-to-use immunochromatographic in vitro test for the quick and accurate detection of IgG and/or IgM antibodies against the chikungunya virus in human serum, plasma, or whole blood samples. It is created with the intention of being used by professionals to assist in the clinical laboratory diagnosis of chikungunya virus infection.

This test kit uses mouse anti-human IgM antibodies as the detection reagent in addition to goat IgG as the capture reagent for the Chikungunya antigen. In the control line system, a mouse anti-goat IgG is used.

The Chikungunya IgM Rapid Test is a point-of-care diagnostic tool that detects IgM antibodies produced by the body in response to the Chikungunya virus. It is a lateral flow chromatographic immunoassay that provides results within 15 minutes. The test can be performed using serum, plasma, or whole blood samples, making it flexible and easy to use. The has several features that make it a reliable and effective diagnostic tool.

1. High Sensitivity

The  has a high level of sensitivity, ensuring that infected individuals are correctly identified. The test has been shown to have a sensitivity of 95% and a specificity of 98%. The accuracy of the test is achieved through its use of monoclonal antibodies that specifically target the Chikungunya virus.

2. Easy to use

The is very easy to use, making it suitable for health care providers with different levels of expertise. The test requires minimal training, and the results are easy to interpret. The kit comes with all the necessary components, including a test cassette, dropper, buffer, and instructions for use.

3. Fast results

The Chikungunya IgM Rapid Test provides results within 15 minutes, which is much faster than traditional laboratory-based tests. This rapid turnaround time allows infected individuals to receive timely treatment and reduce the risk of further spread of the disease.

4. Low Cost

The is an affordable diagnostic tool that is accessible to health care providers in resource-limited settings. The low cost of the test also makes it financially feasible for merchants to purchase and sell to their customers.

1. Before opening the packet, bring it to room temperature. The test equipment should be taken out of the sealed packet and used right away.

2. Set the test instrument down on a smooth, clean surface.

3.Start the timer while holding the dropper vertically and adding 1 drop of the specimen (about 35 l) and 2 drops of the buffer (about 70 l) to the specimen well (S) of the test device. See the example below..

4.Await the appearance of the colored line(s). At 15 minutes, read the findings. After 20 minutes, the outcome should not be interpreted.

Sensitivity and specificity

260 samples total, comprising 70 Chikungunya IgM Rapid Test and 190 negative samples, make up the test findings.

Diagnostic sensitivity:95.7%(95%CI:87.7%~99.0%)*

Diagnostic specificity: 98.4% (95%CI:95.2%~99.7%)*

Total agreement: 97.7% (95%CI:94.9%~99.1%)

The is effective in the diagnosis of Chikungunya virus infection. The test is particularly useful in areas where the disease is prevalent or where cases have been reported. Health care providers can use the test to screen individuals suspected of Chikungunya infection, enabling them to receive timely treatment and reduce disease transmission.

Merchants can purchase the Chikungunya IgM Rapid Test and sell it to hospitals, clinics, and other health care providers. The test can also be marketed to travelers visiting areas where the disease is prevalent, providing them with a convenient and affordable way to screen for infection.

The is an innovative point-of-care diagnostic tool that enables fast and accurate detection of the Chikungunya virus. Its high sensitivity, ease of use, fast results, and affordability make it an attractive product for merchants. The test has a broad range of applications, including screening for Chikungunya virus infection in areas where the disease is prevalent. Merchants can purchase the test and sell it to health care providers and travelers, providing them with a convenient and reliable diagnostic tool.

Hot Tags: chikungunya igm rapid test, China chikungunya igm rapid test manufacturers, suppliers